Search Clinical Trials
585,889 trials
ID
Status
Phase
Title
Sponsor
NCT07601581
A Trial to Determine People's Explicit vs. Implicit Preferences for Gender-inclusive Sexual and Reproductive Health ContentBoston Children's HospitalCompletedNot Applicable
NCT07601581Completed
Not Applicable
A Trial to Determine People's Explicit vs. Implicit Preferences for Gender-inclu...Boston Children's Hospita...
NCT07602621
Video-Assisted Emotional Preparation and Emotional Expression During Subcutaneous Procedures in Children With CancerEge UniversityNot Yet RecruitingNot Applicable
NCT07602621Not Yet Recruiting
Not Applicable
Video-Assisted Emotional Preparation and Emotional Expression During Subcutaneou...Ege University
NCT07601711
Sulbactam-Durlobactam in CRAB Infection: A Real-World Cohort StudySichuan Provincial People's HospitalRecruiting
NCT07601711Recruiting
—
Sulbactam-Durlobactam in CRAB Infection: A Real-World Cohort StudySichuan Provincial People...
NCT07605143
Effects of Immersive Virtual Reality Exercise on Quality of Life, Cognitive Function, and Psychological Symptoms in Individuals With Fibromyalgiagonzalo arias alvarezCompletedNot Applicable
NCT07605143Completed
Not Applicable
Effects of Immersive Virtual Reality Exercise on Quality of Life, Cognitive Func...gonzalo arias alvarez
NCT07603466
Combination Osilodrostat and Cabergoline in Cushing's DiseaseUniversity of BasrahEnrolling By InvitationPhase 4
NCT07603466Enrolling By Invitation
Phase 4
Combination Osilodrostat and Cabergoline in Cushing's DiseaseUniversity of Basrah
NCT07604389
AR Health Education Video for Postoperative Breast Cancer PatientsTungs' Taichung Metroharbour HospitalRecruitingNot Applicable
NCT07604389Recruiting
Not Applicable
AR Health Education Video for Postoperative Breast Cancer PatientsTungs' Taichung Metroharb...
NCT07601295
Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)National Heart, Lung, and Blood Institute (NHLBI)Not Yet RecruitingPhase 2
NCT07601295Not Yet Recruiting
Phase 2
Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of P...National Heart, Lung, and...
NCT07603986
CBT for Anger and Aggression in Children: a Pilot Study of Irritability and SuicidalityChief Scientist, The Israel Ministry of ScienceCompletedNot Applicable
NCT07603986Completed
Not Applicable
CBT for Anger and Aggression in Children: a Pilot Study of Irritability and Suic...Chief Scientist, The Isra...
NCT07600866
Validation of a Body-Composition Segmentation Software on a Diverse Public CT Scan CohortNucleo Research, Inc.Not Yet Recruiting
NCT07600866Not Yet Recruiting
—
Validation of a Body-Composition Segmentation Software on a Diverse Public CT Sc...Nucleo Research, Inc.
NCT07605234
Phase II Single Arm Open Label Study Evaluating the Feasibility and Safety of Photobiomodulation as an Adjunct to Standard Supportive Care for Chemotherapy Induced Oral Mucositis in Pediatric Patients With Hematolymphoid MalignanciesTata Memorial HospitalNot Yet RecruitingNot Applicable
NCT07605234Not Yet Recruiting
Not Applicable
Phase II Single Arm Open Label Study Evaluating the Feasibility and Safety of Ph...Tata Memorial Hospital
NCT07602049
Cryoablation Plus Camrelizumab for Advanced Soft Tissue SarcomaSun Yat-sen UniversityRecruitingPhase 2
NCT07602049Recruiting
Phase 2
Cryoablation Plus Camrelizumab for Advanced Soft Tissue SarcomaSun Yat-sen University
NCT07602933
Photobiomodulation Effects on Fatigue and Muscle Damage Induced by NMESConselho Nacional de Desenvolvimento Científico e TecnológicoNot Yet RecruitingNot Applicable
NCT07602933Not Yet Recruiting
Not Applicable
Photobiomodulation Effects on Fatigue and Muscle Damage Induced by NMESConselho Nacional de Dese...
NCT07603232
Long-Term Health Outcomes in Children Born With Hirschsprung's Disease and Anorectal Malformations at the Colorectal Centre of Excellence in QuebecMcGill University Health Centre/Research Institute of the McGill University Health CentreEnrolling By Invitation
NCT07603232Enrolling By Invitation
—
Long-Term Health Outcomes in Children Born With Hirschsprung's Disease and Anore...McGill University Health...
NCT07604441
Chemotherapy-Induced Peripheral Neuropathy - Additional Evaluation in Breast Cancer SurvivorsUniversity Hospital Schleswig-HolsteinNot Yet RecruitingNot Applicable
NCT07604441Not Yet Recruiting
Not Applicable
Chemotherapy-Induced Peripheral Neuropathy - Additional Evaluation in Breast Can...University Hospital Schle...
NCT07603843
Use of Cognitive Aid Methods in the Management of Status EpilepticusAnkara UniversityNot Yet RecruitingNot Applicable
NCT07603843Not Yet Recruiting
Not Applicable
Use of Cognitive Aid Methods in the Management of Status EpilepticusAnkara University
NCT07604142
Allogenic Bone Block for Oro-Antral Communication Closure for Subsequent Implant PlacementTanta UniversityEnrolling By InvitationNot Applicable
NCT07604142Enrolling By Invitation
Not Applicable
Allogenic Bone Block for Oro-Antral Communication Closure for Subsequent Implant...Tanta University
NCT07604415
Active Versus Passive Anal Sphincter Training in Patients With Fecal IncontinenceComenius UniversityRecruitingNot Applicable
NCT07604415Recruiting
Not Applicable
Active Versus Passive Anal Sphincter Training in Patients With Fecal Incontinenc...Comenius University
NCT07601737
Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell CarcinomaShanghai General Hospital, Shanghai Jiao Tong University School of MedicineRecruitingPhase 2
NCT07601737Recruiting
Phase 2
Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of L...Shanghai General Hospital...
NCT07600684
Preventing Medication Mismanagement in People Living With DementiaHiDO TechnologiesRecruitingNot Applicable
NCT07600684Recruiting
Not Applicable
Preventing Medication Mismanagement in People Living With DementiaHiDO Technologies
Result Breakdown
Not yet recruiting7 (35%)
Recruiting6 (30%)
Completed4 (20%)
Enrolling by invitation3 (15%)
not_applicable13 (65%)
Not Specified3 (15%)
Phase 23 (15%)
Phase 41 (5%)